Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-10 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-03-19 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
ACRX | AcelRx Pharmaceuticals | 1.74 | 0.04 | 2.35% | 198M |
You can purchase shares of AcelRx Pharmaceuticals (NASDAQ: ACRX) through any online brokerage.
Other companies in AcelRx Pharmaceuticals’s space includes: Onconova Therapeutics (NASDAQ:ONTX), SCYNEXIS (NASDAQ:SCYX) and Jaguar Health (NASDAQ:JAGX).
The latest price target for AcelRx Pharmaceuticals (NASDAQ: ACRX) was reported by Credit Suisse on 2020-08-13. The analyst firm set a price target for 0.84 expecting ACRX to fall to within 12 months (a possible -51.72% downside). 3 analyst firms have reported ratings in the last year.
The stock price for AcelRx Pharmaceuticals (NASDAQ: ACRX) is $1.74 last updated Fri Mar 05 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for AcelRx Pharmaceuticals.
There is no upcoming split for AcelRx Pharmaceuticals.